Literature DB >> 7768488

Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone-associated Achilles tendinitis.

P Gillet1, A Blum, D Hestin, J Pourel, C Pierfitte, D Mainard, M Kessler, P Netter.   

Abstract

The aim of this study was to document the accuracy of magnetic resonance imaging (MRI) during fluoroquinolone-associated Achilles tendinitis. Fourteen Achilles tendons were examined by MRI (T1 and T2 or T2*-weighted sequences) in nine patients with typical tendinopathy (13 cases of tendinitis and 1 rupture) during fluoroquinolone therapy. Tendinous involvement was classified according to the prominence of intra- or peritendinous changes. The most typical feature was the presence of intratendinous changes, longitudinal or transversal, detected on T1 or T2-weighted sequences. Peritendinitis was most visible in two cases and nodular involvement in three cases. It was concluded that MRI appears a helpful and accurate method in identifying and classifying such iatrogenic tendinitis. In addition, MRI indicates orthopedic management when detecting risk of rupture.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768488     DOI: 10.1111/j.1472-8206.1995.tb00265.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  3 in total

1.  Levofloxacin-associated Achilles tendinitis in a patient with chronic kidney disease stage 5.

Authors:  Akihiko Kato; Sayaka Ishigaki; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2011-02-16       Impact factor: 2.801

2.  Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions.

Authors:  Areum Durey; Yong Soo Baek; Jin Seok Park; Kwangsoo Lee; Jeong-Seon Ryu; Jin-Soo Lee; Moon-Hyun Cheong
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

3.  Imaging Findings in Two Cases of Fluoroquinolone-Induced Achilles Tendinopathy.

Authors:  Gregory M Sterne; Michael L Richardson; Bill H Warren
Journal:  Radiol Case Rep       Date:  2015-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.